- Home
- ENSC vs AIHS Comparison
ENSC vs AIHS Comparison
Compare ENSC & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- AIHS
- Stock Information
- Founded
- ENSC 2003
- AIHS 2014
- Country
- ENSC United States
- AIHS China
- Employees
- ENSC 8
- AIHS N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- AIHS Finance: Consumer Services
- Sector
- ENSC Health Care
- AIHS Finance
- Exchange
- ENSC Nasdaq
- AIHS Nasdaq
- Market Cap
- ENSC 9.5M
- AIHS 9.7M
- IPO Year
- ENSC N/A
- AIHS 2018
- Fundamental
- Price
- ENSC $0.69
- AIHS $0.85
- Analyst Decision
- ENSC
- AIHS
- Analyst Count
- ENSC 0
- AIHS 0
- Target Price
- ENSC N/A
- AIHS N/A
- AVG Volume (30 Days)
- ENSC 83.4M
- AIHS 19.1K
- Earning Date
- ENSC 11-12-2024
- AIHS 11-19-2024
- Dividend Yield
- ENSC N/A
- AIHS N/A
- EPS Growth
- ENSC N/A
- AIHS N/A
- EPS
- ENSC N/A
- AIHS N/A
- Revenue
- ENSC $4,421,404.00
- AIHS $5,842,114.00
- Revenue This Year
- ENSC N/A
- AIHS N/A
- Revenue Next Year
- ENSC N/A
- AIHS N/A
- P/E Ratio
- ENSC N/A
- AIHS N/A
- Revenue Growth
- ENSC 40.41
- AIHS N/A
- 52 Week Low
- ENSC $0.14
- AIHS $0.20
- 52 Week High
- ENSC $2.06
- AIHS $1.45
- Technical
- Relative Strength Index (RSI)
- ENSC 61.12
- AIHS 39.66
- Support Level
- ENSC $0.62
- AIHS $0.85
- Resistance Level
- ENSC $0.81
- AIHS $0.97
- Average True Range (ATR)
- ENSC 0.15
- AIHS 0.04
- MACD
- ENSC 0.01
- AIHS 0.01
- Stochastic Oscillator
- ENSC 53.71
- AIHS 26.43
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About AIHS Senmiao Technology Limited
Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.